{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-25-024011","form_type":"8-K","ticker":"LPCN","cik":"0001535955","company_name":"Lipocine Inc.","filed_at":"2025-11-18T23:59:59+00:00","discovered_at":"2026-05-14T18:02:39.680907+00:00","generated_at":"2026-05-16T18:46:34.184706+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Lipocine reports promising interim safety for LPCN 1154 in Phase 3 PPD trial; topline Q2 2026","bullets":["DSMB review after one-third of planned 80 participants (n=30) recommended continuation as planned without modification.","47 participants completed dosing with no dose reductions, discontinuations, drug-related SAEs, loss of consciousness, or excessive sedation.","Topline results on track for Q2 2026; second DSMB and safety update targeted early Q1 2026.","Phase 3 data expected to support 505(b)(2) NDA submission for LPCN 1154 later in 2026.","Trial conducted entirely in outpatient setting per FDA feedback; 19 U.S. clinical sites participating."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-25-024011","json":"https://secwatch.observer/filing/0001493152-25-024011.json","markdown":"https://secwatch.observer/filing/0001493152-25-024011.md","text":"https://secwatch.observer/filing/0001493152-25-024011.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1535955/000149315225024011/0001493152-25-024011-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1535955/000149315225024011/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T18:46:34.184706+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}